Data / Drug companies / CKD Bio Corporation
CKD Bio Corporation: 14 products in the FDA NDC directory, labeler code 52972
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
CKD Bio Corporation (labeler code 52972) lists 14 products in the FDA National Drug Code Directory. By type: 11 bulk ingredients, 3 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on July 26, 2023.
The request: Watch CKD Bio Corporation (FDA labeler code 52972): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52972
- Products in commercial distribution
- 14
- Packages
- 14
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 19, 1996
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 11 | 78.6% |
| Drugs for further processing | 3 | 21.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 11 | 78.6% |
| Drugs for further processing | 3 | 21.4% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 14 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Clavulanate potassium | 52972-0042 | Powder | Drugs for further processing | July 26, 2023 |
| Vancomycin hydrochloride | 52972-0039 | Powder | Bulk ingredients | October 31, 2016 |
| Tacrolimus | 52972-0040 | Powder | Bulk ingredients | September 29, 2016 |
| Rifamycin o | 52972-0038 | Powder | Bulk ingredients | June 21, 2012 |
| Mycophenolate mofetil | 52972-0037 | Powder | Bulk ingredients | June 7, 2011 |
| Rifamycin sodium | 52972-0036 | Powder | Bulk ingredients | April 26, 2010 |
| Acarbose | 52972-0035 | Powder | Bulk ingredients | September 12, 2007 |
| Clavulanate potassium | 52972-0034 | Powder | Drugs for further processing | June 10, 2005 |
| Clavulanate potassium | 52972-0033 | Powder | Drugs for further processing | June 10, 2005 |
| Clavulanate potassium | 52972-0031 | Powder | Bulk ingredients | February 26, 2003 |
| Rifampin | 52972-0041 | Powder | Bulk ingredients | November 16, 1998 |
| Demeclocycline hydrochloride | 52972-0030 | Powder | Bulk ingredients | November 16, 1998 |
| Rifampin | 52972-0026 | Powder | Bulk ingredients | November 16, 1998 |
| Cyclosporine | 52972-0027 | Powder | Bulk ingredients | November 19, 1996 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.